Register for free to listen to this article
Listen with Speechify
0:00
2:00
PITTSBURGH—The University of Pittsburgh and UPMC haveentered into a partnership with Johnson & Johnson Corporate Office ofScience and Technology (COSAT) to support translational research, whichtransforms lab findings into usable products and services, by jointlyallocating research monies to university faculty from a mutually establishedfund.
 
 
COSAT has a long history of supporting the development oftechnologies through collaboration with academic institutions, and Pitt holds astrong record of moving basic scientific research from the lab to the patient'sbedside. The new agreement is designed to improve the speed of development ofearly stage Pitt technologies that hold the greatest potential to benefitpatients and improve services delivered by the healthcare system.
 
 
Pitt will lead a committee including representatives fromCOSAT and UPMC to identify projects of promise that could benefit from fundingsupport. As with other research efforts, intellectual property or technologiesdeveloped at Pitt through this program will be owned by the university and madeavailable through licensing agreements to industry collaborators throughwell-established procedures.
 
 
Dr. Arthur S. Levine, Pitt's senior vice chancellor for thehealth sciences and dean, School of Medicine, notes that "the university hastremendous capabilities in all aspects of biomedical research. This newpartnership with COSAT will foster the continued development of high-caliberwork with great scientific and therapeutic potential."
 
 
The university and UPMC recently formed a pharmaceuticalcollaboration committee to address how best to work with the pharmaceutical andbiotech industries, including the co-mingled COSAT fund. The committee is ledby Dr. D. Lansing Taylor, director of Pitt's Drug Discovery Institute andAllegheny Foundation Professor of Computational and Systems Biology, andcomposed of faculty from the Dietrich School of Arts and Sciences and theSchools of Medicine and Pharmacy, as well as staff from the university's Officeof Technology Management and UPMC.

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue